Skip to content

HELICOS BIOSCIENCES CORP

Delisted

CIK 1274563fmd_1XHKEZ86RVZ67D9PM6GFP75D4EManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2004 to Jun 30, 2012, 15 periods

Latest annual · FY2011

Millions
Total revenues
3
Gross profit
3
Operating income
(6)
Net income
(6)
Free cash flow
(12)

Latest quarter · Q2 FY2012

Millions
Total revenues
1
Gross profit
1
Operating income
(1)
Net income
(0)
Free cash flow
0
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2008 to FY2011
n/m
Revenue, 5 yearsFY2006 to FY2011
n/m
Net income, 5 yearsFY2006 to FY2011
n/m

HELICOS BIOSCIENCES CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2011FY2010ChangeSource
Revenue$3.2 million$4.4 million-26.5%10-K 2012-03-30 · proof
Gross profit$3 million$3.7 million-18.4%10-K 2012-03-30 · proof
Operating income-$6 million-$22.8 million10-K 2012-03-30 · proof
Net income-$5.8 million-$18.8 million10-K 2012-03-30 · proof
Cash from operating activities-$941,000-$12 million10-K 2012-03-30 · proof
Total assets$2.6 million$7 million-63.4%10-K 2012-03-30 · proof
Total liabilities$13.5 million$13.2 million+2.5%10-K 2012-03-30 · proof
Cash and cash equivalents$999,000$2.5 million-60.2%10-K 2012-03-30 · proof
Total debt$3.1 million$3.5 million-8.9%10-Q 2012-05-14 · proof
What was HELICOS BIOSCIENCES CORP's revenue in fiscal 2011?
HELICOS BIOSCIENCES CORP reported revenue of $3.2 million for fiscal 2011 (the year ended Dec 31, 2011), against $4.4 million the year before (-26.5%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What was HELICOS BIOSCIENCES CORP's gross profit in fiscal 2011?
HELICOS BIOSCIENCES CORP reported gross profit of $3 million for fiscal 2011 (the year ended Dec 31, 2011), against $3.7 million the year before (-18.4%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What was HELICOS BIOSCIENCES CORP's operating income in fiscal 2011?
HELICOS BIOSCIENCES CORP reported operating income of -$6 million for fiscal 2011 (the year ended Dec 31, 2011), against -$22.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What was HELICOS BIOSCIENCES CORP's net income in fiscal 2011?
HELICOS BIOSCIENCES CORP reported net income of -$5.8 million for fiscal 2011 (the year ended Dec 31, 2011), against -$18.8 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What was HELICOS BIOSCIENCES CORP's cash from operating activities in fiscal 2011?
HELICOS BIOSCIENCES CORP reported cash from operating activities of -$941,000 for fiscal 2011 (the year ended Dec 31, 2011), against -$12 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What are HELICOS BIOSCIENCES CORP's total assets?
As of Dec 31, 2011, HELICOS BIOSCIENCES CORP reported total assets of $2.6 million, against $7 million a year earlier (-63.4%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What are HELICOS BIOSCIENCES CORP's total liabilities?
As of Dec 31, 2011, HELICOS BIOSCIENCES CORP reported total liabilities of $13.5 million, against $13.2 million a year earlier (+2.5%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What are HELICOS BIOSCIENCES CORP's cash and cash equivalents?
As of Dec 31, 2011, HELICOS BIOSCIENCES CORP reported cash and cash equivalents of $999,000, against $2.5 million a year earlier (-60.2%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
What is HELICOS BIOSCIENCES CORP's total debt?
As of Dec 31, 2011, HELICOS BIOSCIENCES CORP reported total debt of $3.1 million, against $3.5 million a year earlier (-8.9%). Source: the 10-Q filed with the SEC on May 14, 2012. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1274563&period_type=annual&limit=5"

Information only, not investment advice.